Prakash Diwan of Altamount Capital Management recommends buying Sun Pharma Advanced Research Company with a target price of Rs 134.50 and stop loss at Rs 127.50.
first published: Jul 4, 2013 01:39 pm
A collection of the most-viewed Moneycontrol videos.
U.S.-Iran Conflict Will Have Huge Impact On Global Markets, Businesses, Supply Chain: Nalin Mehta
Rising Bharat Summit 2026 | “Satellite Can Go Where Others Can’t” – Jyotiraditya Scindia
Rising Bharat Summit 2026 | “AI Creates More Opportunities” – Jyotiraditya Scindia
Rising Bharat Summit 2026 | Piyush Goyal Answers the Big India–US Trade Deal Question
